Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Predicting checkpoint inhibitor-associated autoimmune diabetes: prospects and limitations.
Journal: The Journal of clinical investigation
Published: February 16, 2026
Towards insulin independence in type 1 diabetes: Prospects for prevention and cure.
Journal: PLoS medicine
Published: November 25, 2025
Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients.
Journal: Frontiers in endocrinology
Published: September 02, 2025
Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.
Journal: Journal for immunotherapy of cancer
Published: August 27, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: July 21, 2025
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreas.
Journal: Journal for immunotherapy of cancer
Published: July 07, 2025
Anti-CD3 mAb treatment reshapes infiltrating T and β cells in the islets in autoimmune diabetes.
Journal: JCI insight
Published: February 28, 2025
CTLA-4 blockade shifts the B cell repertoire toward autoimmunity.
Journal: The Journal of clinical investigation
Published: November 11, 2024
Checkpoint Inhibitor-Induced Autoimmune Diabetes: An Autoinflammatory Disease.
Journal: Cold Spring Harbor perspectives in medicine
Published: July 22, 2024
Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng.
Journal: Journal for immunotherapy of cancer
Published: June 01, 2023
Last Updated: 09/26/2026